Frequency of Neuropathy Symptoms in Diabetic Patients

Keywords: Diabetes mellitus, Diabetic neuropathies, Michigan neuropathy screening instrument (MNSI), Peripheral nerve injury

Abstract


Background/Aim: One of the most common consequences of diabetes mellitus is diabetic neuropathy, which is triggered on by nerve damage. The characteristic of neuropathies is a progressive loss of nerve fibre function resulting in numbness, tingling, aching, burning and throbbing sensations. In addition, it adds to the risk of falls, joint deformities, muscular atrophy and foot ulcers. The study aimed to analyse the incidence of motor and sensory dysfunctions in patients with diabetes mellitus in Chennai, India.

Methods: This was an observational study of analytic type. Clinically diagnosed diabetic patients between the age of 45 to 60 years were considered for this study. Patients who consented to participate in this study, with a history of diabetes mellitus spanning more than ten years were chosen. Patients found to have other causes of neuropathy, diabetic ulceration, lactating (or) pregnant women and non-cooperative patients were excluded from this study. All the subjects enrolled in the study at the aforementioned centres were given the Michigan neuropathy screening instrument (MNSI). Total score of MNSI was calculated and interpreted for the prevalence.

Results: A total of 246 subjects have participated in this study out of which 54 % were male and 46 % were female, 127 (51 %) had diabetic peripheral neuropathy, 41 (17 %) had partial diabetic neuropathy and 78 (32 %) had no symptoms of diabetic neuropathy.

Conclusion: Through the questionnaire and physical examination, the current study demonstrated a high prevalence of motor and sensory impairments as well as diabetic neuropathy symptoms in the diabetic population.

References

American Diabetes Association. Introduction: standards of medical care in diabetes-2022. Diabetes Care. 2022 Jan 1;45(Suppl 1):S1-S2. doi: 10.2337/dc22-Sint.

Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012 Jun;11(6):521-34. doi: 10.1016/S1474-4422(12)70065-0.

Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler Pet al; Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010 Oct;33(10):2285-93. doi: 10.2337/dc10-1303.

Dixit S, Maiya A. Diabetic peripheral neuropathy and its evaluation in a clinical scenario: A review. J Postgrad Med. 2014;60(1):33-40. doi: 10.4103/0022-3859.128805.

Sloan G, Selvarajah D, Tesfaye S. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nature Rev Endocrinol. 2021 May 28;17. doi: 10.1038/s41574-021-00496-z.

Vinik AI, Erbas T. Diabetic autonomic neuropathy. Handb Clin Neurol. 2014;126:63-79. doi: 10.1016/B978-0-444-53491-0.00022-5.

Kanaya AM, Herrington D, Vittinghoff E, Ewing SK, Liu K, Blaha MJ, et al. Understanding the high prevalence of diabetes in U.S. south Asians compared with four racial/ethnic groups: the MASALA and MESA studies. Diabetes Care. 2014 Jun;37(6):1621-8. doi: 10.2337/dc13-2656.

Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res. 2007 Mar;125(3):217-30. PMID: 17496352.

Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al; American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005 Apr;28(4):956-62. doi: 10.2337/diacare.28.4.956.

Ang L, Cowdin N, Mizokami-Stout K, Pop-Busui R. Update on the management of diabetic neuropathy. Diabetes Spectr. 2018 Aug;31(3):224-33. doi: 10.2337/ds18-0036.

Ismail L, Materwala H, Al Kaabi J. Association of risk factors with type 2 diabetes: A systematic review. Comput Struct Biotechnol J. 2021 Mar 10;19:1759-85. doi: 10.1016/j.csbj.2021.03.003.

Akkus G, Sert M. Diabetic foot ulcers: A devastating complication of diabetes mellitus continues non-stop in spite of new medical treatment modalities. World J Diabetes. 2022;13(12):1106–21. doi: 10.4239/wjd.v13.i12.1106.

MD Abu Bashar, Verma M. Prevalence and Determinants of Diabetic Peripheral Neuropathy/Foot Syndrome in the Rural population of North India. Iberoam J Med 2021;3(1):18-25. doi: 10.5281/zenodo.4393501.

American Diabetes Association Professional Practice Committee. 12. retinopathy, neuropathy, and foot care: standards of care in diabetes-2024. Diabetes Care. 2024 Jan 1;47(Suppl 1):S231-S243. doi: 10.2337/dc24-S012.

Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017 Jan;40(1):136-54. doi: 10.2337/dc16-2042.

Shillo P, Yiangou Y, Donatien P, Greig M, Selvarajah D, Wilkinson ID, et al. Nerve and vascular biomarkers in skin biopsies differentiate painful from painless peripheral neuropathy in type 2 diabetes. Front Pain Res (Lausanne). 2021 Oct 22;2:731658. doi: 10.3389/fpain.2021.731658.

Sher EK, Prnjavorac B, Farhat EK, Palić B, Ansar S, Sher F. Effect of diabetic neuropathy on reparative ability and immune response system. Mol Biotechnol. 2023 Jul 31. doi: 10.1007/s12033-023-00813-z.

Zochodne DW. Diabetes mellitus and the peripheral nervous system: manifestations and mechanisms. Muscle Nerve. 2007 Aug;36(2):144-66. doi: 10.1002/mus.20785.

Sujata, Thakur R. Unequal burden of equal risk factors of diabetes between different gender in India: a cross-sectional analysis. Sci Rep. 2021 Nov 22;11(1):22653. doi: 10.1038/s41598-021-02012-9.

Galiero R, Caturano A, Vetrano E, Beccia D, Brin C, Alfano M, et al. Peripheral neuropathy in diabetes mellitus: pathogenetic mechanisms and diagnostic options. Int J Mol Sci. 2023 Feb 10;24(4):3554. doi: 10.3390/ijms24043554.

Toma AI, Fuller JM, Willett NJ, Goudy SL. Oral wound healing models and emerging regenerative therapies. Translat Res. 2021 Oct;236:17–34. doi: 10.1016/j.trsl.2021.06.003.

Boulton AJM, Armstrong DG, Kirsner RS, Attinger CE, Lavery LA, Lipsky BA, et al. Diagnosis and management of diabetic foot complications. Arlington (VA): American Diabetes Association; 2018 Oct. doi: 10.2337/db20182-1.

Hingorani A, LaMuraglia GM, Henke P, Meissner MH, Loretz L, Zinszer KM, et al. The management of diabetic foot: A clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. J Vasc Surg. 2016 Feb;63(2 Suppl):3S-21S. doi: 10.1016/j.jvs.2015.10.003.

Krishnamoorthy S, Pandurangan V, Varadan S, Gopalan S, Singh S RB. Clinical characteristics and hospitalisation outcomes of hypoglycaemia in hospitalised patients with type 2 diabetes mellitus. Scr Med. 2024 May-Jun;55(3):287-96. doi: 10.5937/scriptamed55-50079.

Yang Z, Zhang Y, Chen R, Huang Y, Ji L, Sun F, et al. Simple tests to screen for diabetic peripheral neuropathy. Cochrane Database Syst Rev. 2018 Jul 30;2018(7):CD010975. doi: 10.1002/14651858.CD010975.pub2.

Ennion L, Hijmans J. Improving vibration perception in a patient with type 2 diabetes and sensory peripheral neuropathy. South African J Physiot. 2019 Jul 25;75(1). doi: 10.1016/j.trsl.2021.06.003.

Baraz S, Zarea K, Shahbazian H, Latifi S. Comparison of the accuracy of monofilament testing at various points of feet in peripheral diabetic neuropathy screening. J Diabetes Metabol Disor. 2014;13(1):19. doi: 10.1186/2251-6581-13-19.

Published
2024/10/23
Section
Original article